MedComm-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2200373, encodeId=79e422003e3dd, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：遗传学 经验分享：期刊目前还属于ESCI，非SCI。审稿速度慢，审稿人和编辑都很负责任。文章接受后等online花了将近3个月时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6495142178, createdName=smmm, createdTime=Thu Apr 25 16:52:34 CST 2024, time=2024-04-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2195131, encodeId=be792195131fe, content=审稿速度:12.0 经验分享：看了评论好像都要接受三轮修稿啊，是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fd835167, createdName=liuzhengtao, createdTime=Mon Mar 25 01:48:53 CST 2024, time=2024-03-25, status=1, ipAttribution=明尼苏达), GetPortalCommentsPageByObjectIdResponse(id=2192508, encodeId=f4ed219250817, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审4个月左右，大修，2个月后返稿继续under review中。 听说SCI目录每个月都会更新，什么时候才能进入SCIE的库呢？目前中科院分区是3区是吗？有没有知情人士说下，毕竟现在大部分院校都不承认ESCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db684799778, createdName=362595009, createdTime=Mon Mar 11 12:10:27 CST 2024, time=2024-03-11, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2189981, encodeId=96e221899819a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤药理 经验分享：23年6月2投，今天2024年2月28接收，来来回回三轮revise，只能说对文章的要求真的高，23年IF肯定＞10了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Wed Feb 28 22:00:43 CST 2024, time=2024-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2175362, encodeId=981121e536202, content=修回之后under review之后变成pending recommendation，但是后来又under review了。这是有审稿人不满意吗，还是审稿人不够啊…而且也太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epxYEMeM41N9n76P8Xn6Fy2L47YtWpP4fVuUZMZSAYnf6zW01CJWE2u7iaMTUicChIOKdsvNibjS3q7w/0, createdBy=f1fd2219511, createdName=ms5078924656919134, createdTime=Sun Dec 17 03:09:26 CST 2023, time=2023-12-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193141, encodeId=ac452193141fb, content=审稿速度:1.0 偏重的研究方向：综述 经验分享：有人知道Under Review之后的Pending Recommendation是什么意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b48657909, createdName=ms2000001264592817, createdTime=Thu Mar 14 12:04:29 CST 2024, time=2024-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172808, encodeId=92fa21e2808ca, content=偏重的研究方向：临床医学 经验分享：投了四个半月还没有消息，这个期刊审稿真的好慢啊，国内好多单位都不认可ESCI的文章，这个还值得等吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vNZqQTZRAia4sz17MJeeXej9b0wqlA3jB6Acygq3dDKMnrkfLkfWibEKTPDtP1BmicPE93J1B6Z7iam0nDL5wialt9g/132, createdBy=6bee2434254, createdName=琳琳LL, createdTime=Mon Dec 04 10:34:00 CST 2023, time=2023-12-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2185051, encodeId=edca2185051ae, content=请问大家Under Review是外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Wed Jan 31 16:07:51 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183392, encodeId=d2db2183392ce, content=急急急！！！各位大佬，有人知道medcomm期刊查重用的是什么软件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adaa8754937, createdName=ms9000001623527020, createdTime=Tue Jan 23 10:44:47 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166798, encodeId=80212166e98b4, content=有人知道这个期刊什么时候能进SCIE么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sun Nov 05 13:50:31 CST 2023, time=2023-11-05, status=1, ipAttribution=江苏省)]

2024-04-25 smmm 来自浙江省

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：遗传学
经验分享：期刊目前还属于ESCI，非SCI。审稿速度慢，审稿人和编辑都很负责任。文章接受后等online花了将近3个月时间。

4 0

[GetPortalCommentsPageByObjectIdResponse(id=2200373, encodeId=79e422003e3dd, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：遗传学 经验分享：期刊目前还属于ESCI，非SCI。审稿速度慢，审稿人和编辑都很负责任。文章接受后等online花了将近3个月时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6495142178, createdName=smmm, createdTime=Thu Apr 25 16:52:34 CST 2024, time=2024-04-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2195131, encodeId=be792195131fe, content=审稿速度:12.0 经验分享：看了评论好像都要接受三轮修稿啊，是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fd835167, createdName=liuzhengtao, createdTime=Mon Mar 25 01:48:53 CST 2024, time=2024-03-25, status=1, ipAttribution=明尼苏达), GetPortalCommentsPageByObjectIdResponse(id=2192508, encodeId=f4ed219250817, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审4个月左右，大修，2个月后返稿继续under review中。 听说SCI目录每个月都会更新，什么时候才能进入SCIE的库呢？目前中科院分区是3区是吗？有没有知情人士说下，毕竟现在大部分院校都不承认ESCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db684799778, createdName=362595009, createdTime=Mon Mar 11 12:10:27 CST 2024, time=2024-03-11, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2189981, encodeId=96e221899819a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤药理 经验分享：23年6月2投，今天2024年2月28接收，来来回回三轮revise，只能说对文章的要求真的高，23年IF肯定＞10了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Wed Feb 28 22:00:43 CST 2024, time=2024-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2175362, encodeId=981121e536202, content=修回之后under review之后变成pending recommendation，但是后来又under review了。这是有审稿人不满意吗，还是审稿人不够啊…而且也太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epxYEMeM41N9n76P8Xn6Fy2L47YtWpP4fVuUZMZSAYnf6zW01CJWE2u7iaMTUicChIOKdsvNibjS3q7w/0, createdBy=f1fd2219511, createdName=ms5078924656919134, createdTime=Sun Dec 17 03:09:26 CST 2023, time=2023-12-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193141, encodeId=ac452193141fb, content=审稿速度:1.0 偏重的研究方向：综述 经验分享：有人知道Under Review之后的Pending Recommendation是什么意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b48657909, createdName=ms2000001264592817, createdTime=Thu Mar 14 12:04:29 CST 2024, time=2024-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172808, encodeId=92fa21e2808ca, content=偏重的研究方向：临床医学 经验分享：投了四个半月还没有消息，这个期刊审稿真的好慢啊，国内好多单位都不认可ESCI的文章，这个还值得等吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vNZqQTZRAia4sz17MJeeXej9b0wqlA3jB6Acygq3dDKMnrkfLkfWibEKTPDtP1BmicPE93J1B6Z7iam0nDL5wialt9g/132, createdBy=6bee2434254, createdName=琳琳LL, createdTime=Mon Dec 04 10:34:00 CST 2023, time=2023-12-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2185051, encodeId=edca2185051ae, content=请问大家Under Review是外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Wed Jan 31 16:07:51 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183392, encodeId=d2db2183392ce, content=急急急！！！各位大佬，有人知道medcomm期刊查重用的是什么软件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adaa8754937, createdName=ms9000001623527020, createdTime=Tue Jan 23 10:44:47 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166798, encodeId=80212166e98b4, content=有人知道这个期刊什么时候能进SCIE么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sun Nov 05 13:50:31 CST 2023, time=2023-11-05, status=1, ipAttribution=江苏省)]

2024-03-25 liuzhengtao 来自明尼苏达

审稿速度:12.0
经验分享：看了评论好像都要接受三轮修稿啊，是吗

14 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200373, encodeId=79e422003e3dd, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：遗传学 经验分享：期刊目前还属于ESCI，非SCI。审稿速度慢，审稿人和编辑都很负责任。文章接受后等online花了将近3个月时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6495142178, createdName=smmm, createdTime=Thu Apr 25 16:52:34 CST 2024, time=2024-04-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2195131, encodeId=be792195131fe, content=审稿速度:12.0 经验分享：看了评论好像都要接受三轮修稿啊，是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fd835167, createdName=liuzhengtao, createdTime=Mon Mar 25 01:48:53 CST 2024, time=2024-03-25, status=1, ipAttribution=明尼苏达), GetPortalCommentsPageByObjectIdResponse(id=2192508, encodeId=f4ed219250817, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审4个月左右，大修，2个月后返稿继续under review中。 听说SCI目录每个月都会更新，什么时候才能进入SCIE的库呢？目前中科院分区是3区是吗？有没有知情人士说下，毕竟现在大部分院校都不承认ESCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db684799778, createdName=362595009, createdTime=Mon Mar 11 12:10:27 CST 2024, time=2024-03-11, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2189981, encodeId=96e221899819a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤药理 经验分享：23年6月2投，今天2024年2月28接收，来来回回三轮revise，只能说对文章的要求真的高，23年IF肯定＞10了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Wed Feb 28 22:00:43 CST 2024, time=2024-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2175362, encodeId=981121e536202, content=修回之后under review之后变成pending recommendation，但是后来又under review了。这是有审稿人不满意吗，还是审稿人不够啊…而且也太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epxYEMeM41N9n76P8Xn6Fy2L47YtWpP4fVuUZMZSAYnf6zW01CJWE2u7iaMTUicChIOKdsvNibjS3q7w/0, createdBy=f1fd2219511, createdName=ms5078924656919134, createdTime=Sun Dec 17 03:09:26 CST 2023, time=2023-12-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193141, encodeId=ac452193141fb, content=审稿速度:1.0 偏重的研究方向：综述 经验分享：有人知道Under Review之后的Pending Recommendation是什么意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b48657909, createdName=ms2000001264592817, createdTime=Thu Mar 14 12:04:29 CST 2024, time=2024-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172808, encodeId=92fa21e2808ca, content=偏重的研究方向：临床医学 经验分享：投了四个半月还没有消息，这个期刊审稿真的好慢啊，国内好多单位都不认可ESCI的文章，这个还值得等吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vNZqQTZRAia4sz17MJeeXej9b0wqlA3jB6Acygq3dDKMnrkfLkfWibEKTPDtP1BmicPE93J1B6Z7iam0nDL5wialt9g/132, createdBy=6bee2434254, createdName=琳琳LL, createdTime=Mon Dec 04 10:34:00 CST 2023, time=2023-12-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2185051, encodeId=edca2185051ae, content=请问大家Under Review是外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Wed Jan 31 16:07:51 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183392, encodeId=d2db2183392ce, content=急急急！！！各位大佬，有人知道medcomm期刊查重用的是什么软件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adaa8754937, createdName=ms9000001623527020, createdTime=Tue Jan 23 10:44:47 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166798, encodeId=80212166e98b4, content=有人知道这个期刊什么时候能进SCIE么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sun Nov 05 13:50:31 CST 2023, time=2023-11-05, status=1, ipAttribution=江苏省)]

2024-03-11 362595009 来自宁夏

审稿速度:6.0 | 投稿命中率:25.0
经验分享：一审4个月左右，大修，2个月后返稿继续under review中。
听说SCI目录每个月都会更新，什么时候才能进入SCIE的库呢？目前中科院分区是3区是吗？有没有知情人士说下，毕竟现在大部分院校都不承认ESCI

20 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200373, encodeId=79e422003e3dd, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：遗传学 经验分享：期刊目前还属于ESCI，非SCI。审稿速度慢，审稿人和编辑都很负责任。文章接受后等online花了将近3个月时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6495142178, createdName=smmm, createdTime=Thu Apr 25 16:52:34 CST 2024, time=2024-04-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2195131, encodeId=be792195131fe, content=审稿速度:12.0 经验分享：看了评论好像都要接受三轮修稿啊，是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fd835167, createdName=liuzhengtao, createdTime=Mon Mar 25 01:48:53 CST 2024, time=2024-03-25, status=1, ipAttribution=明尼苏达), GetPortalCommentsPageByObjectIdResponse(id=2192508, encodeId=f4ed219250817, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审4个月左右，大修，2个月后返稿继续under review中。 听说SCI目录每个月都会更新，什么时候才能进入SCIE的库呢？目前中科院分区是3区是吗？有没有知情人士说下，毕竟现在大部分院校都不承认ESCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db684799778, createdName=362595009, createdTime=Mon Mar 11 12:10:27 CST 2024, time=2024-03-11, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2189981, encodeId=96e221899819a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤药理 经验分享：23年6月2投，今天2024年2月28接收，来来回回三轮revise，只能说对文章的要求真的高，23年IF肯定＞10了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Wed Feb 28 22:00:43 CST 2024, time=2024-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2175362, encodeId=981121e536202, content=修回之后under review之后变成pending recommendation，但是后来又under review了。这是有审稿人不满意吗，还是审稿人不够啊…而且也太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epxYEMeM41N9n76P8Xn6Fy2L47YtWpP4fVuUZMZSAYnf6zW01CJWE2u7iaMTUicChIOKdsvNibjS3q7w/0, createdBy=f1fd2219511, createdName=ms5078924656919134, createdTime=Sun Dec 17 03:09:26 CST 2023, time=2023-12-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193141, encodeId=ac452193141fb, content=审稿速度:1.0 偏重的研究方向：综述 经验分享：有人知道Under Review之后的Pending Recommendation是什么意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b48657909, createdName=ms2000001264592817, createdTime=Thu Mar 14 12:04:29 CST 2024, time=2024-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172808, encodeId=92fa21e2808ca, content=偏重的研究方向：临床医学 经验分享：投了四个半月还没有消息，这个期刊审稿真的好慢啊，国内好多单位都不认可ESCI的文章，这个还值得等吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vNZqQTZRAia4sz17MJeeXej9b0wqlA3jB6Acygq3dDKMnrkfLkfWibEKTPDtP1BmicPE93J1B6Z7iam0nDL5wialt9g/132, createdBy=6bee2434254, createdName=琳琳LL, createdTime=Mon Dec 04 10:34:00 CST 2023, time=2023-12-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2185051, encodeId=edca2185051ae, content=请问大家Under Review是外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Wed Jan 31 16:07:51 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183392, encodeId=d2db2183392ce, content=急急急！！！各位大佬，有人知道medcomm期刊查重用的是什么软件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adaa8754937, createdName=ms9000001623527020, createdTime=Tue Jan 23 10:44:47 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166798, encodeId=80212166e98b4, content=有人知道这个期刊什么时候能进SCIE么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sun Nov 05 13:50:31 CST 2023, time=2023-11-05, status=1, ipAttribution=江苏省)]

2024-02-28 145fac5am20暂无昵称来自上海

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤药理
经验分享：23年6月2投，今天2024年2月28接收，来来回回三轮revise，只能说对文章的要求真的高，23年IF肯定＞10了！

20 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200373, encodeId=79e422003e3dd, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：遗传学 经验分享：期刊目前还属于ESCI，非SCI。审稿速度慢，审稿人和编辑都很负责任。文章接受后等online花了将近3个月时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6495142178, createdName=smmm, createdTime=Thu Apr 25 16:52:34 CST 2024, time=2024-04-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2195131, encodeId=be792195131fe, content=审稿速度:12.0 经验分享：看了评论好像都要接受三轮修稿啊，是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fd835167, createdName=liuzhengtao, createdTime=Mon Mar 25 01:48:53 CST 2024, time=2024-03-25, status=1, ipAttribution=明尼苏达), GetPortalCommentsPageByObjectIdResponse(id=2192508, encodeId=f4ed219250817, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审4个月左右，大修，2个月后返稿继续under review中。 听说SCI目录每个月都会更新，什么时候才能进入SCIE的库呢？目前中科院分区是3区是吗？有没有知情人士说下，毕竟现在大部分院校都不承认ESCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db684799778, createdName=362595009, createdTime=Mon Mar 11 12:10:27 CST 2024, time=2024-03-11, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2189981, encodeId=96e221899819a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤药理 经验分享：23年6月2投，今天2024年2月28接收，来来回回三轮revise，只能说对文章的要求真的高，23年IF肯定＞10了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Wed Feb 28 22:00:43 CST 2024, time=2024-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2175362, encodeId=981121e536202, content=修回之后under review之后变成pending recommendation，但是后来又under review了。这是有审稿人不满意吗，还是审稿人不够啊…而且也太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epxYEMeM41N9n76P8Xn6Fy2L47YtWpP4fVuUZMZSAYnf6zW01CJWE2u7iaMTUicChIOKdsvNibjS3q7w/0, createdBy=f1fd2219511, createdName=ms5078924656919134, createdTime=Sun Dec 17 03:09:26 CST 2023, time=2023-12-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193141, encodeId=ac452193141fb, content=审稿速度:1.0 偏重的研究方向：综述 经验分享：有人知道Under Review之后的Pending Recommendation是什么意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b48657909, createdName=ms2000001264592817, createdTime=Thu Mar 14 12:04:29 CST 2024, time=2024-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172808, encodeId=92fa21e2808ca, content=偏重的研究方向：临床医学 经验分享：投了四个半月还没有消息，这个期刊审稿真的好慢啊，国内好多单位都不认可ESCI的文章，这个还值得等吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vNZqQTZRAia4sz17MJeeXej9b0wqlA3jB6Acygq3dDKMnrkfLkfWibEKTPDtP1BmicPE93J1B6Z7iam0nDL5wialt9g/132, createdBy=6bee2434254, createdName=琳琳LL, createdTime=Mon Dec 04 10:34:00 CST 2023, time=2023-12-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2185051, encodeId=edca2185051ae, content=请问大家Under Review是外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Wed Jan 31 16:07:51 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183392, encodeId=d2db2183392ce, content=急急急！！！各位大佬，有人知道medcomm期刊查重用的是什么软件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adaa8754937, createdName=ms9000001623527020, createdTime=Tue Jan 23 10:44:47 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166798, encodeId=80212166e98b4, content=有人知道这个期刊什么时候能进SCIE么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sun Nov 05 13:50:31 CST 2023, time=2023-11-05, status=1, ipAttribution=江苏省)]

2023-12-17 ms5078924656919134 来自上海

修回之后under review之后变成pending recommendation，但是后来又under review了。这是有审稿人不满意吗，还是审稿人不够啊…而且也太慢太慢了

44 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200373, encodeId=79e422003e3dd, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：遗传学 经验分享：期刊目前还属于ESCI，非SCI。审稿速度慢，审稿人和编辑都很负责任。文章接受后等online花了将近3个月时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6495142178, createdName=smmm, createdTime=Thu Apr 25 16:52:34 CST 2024, time=2024-04-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2195131, encodeId=be792195131fe, content=审稿速度:12.0 经验分享：看了评论好像都要接受三轮修稿啊，是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fd835167, createdName=liuzhengtao, createdTime=Mon Mar 25 01:48:53 CST 2024, time=2024-03-25, status=1, ipAttribution=明尼苏达), GetPortalCommentsPageByObjectIdResponse(id=2192508, encodeId=f4ed219250817, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审4个月左右，大修，2个月后返稿继续under review中。 听说SCI目录每个月都会更新，什么时候才能进入SCIE的库呢？目前中科院分区是3区是吗？有没有知情人士说下，毕竟现在大部分院校都不承认ESCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db684799778, createdName=362595009, createdTime=Mon Mar 11 12:10:27 CST 2024, time=2024-03-11, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2189981, encodeId=96e221899819a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤药理 经验分享：23年6月2投，今天2024年2月28接收，来来回回三轮revise，只能说对文章的要求真的高，23年IF肯定＞10了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Wed Feb 28 22:00:43 CST 2024, time=2024-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2175362, encodeId=981121e536202, content=修回之后under review之后变成pending recommendation，但是后来又under review了。这是有审稿人不满意吗，还是审稿人不够啊…而且也太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epxYEMeM41N9n76P8Xn6Fy2L47YtWpP4fVuUZMZSAYnf6zW01CJWE2u7iaMTUicChIOKdsvNibjS3q7w/0, createdBy=f1fd2219511, createdName=ms5078924656919134, createdTime=Sun Dec 17 03:09:26 CST 2023, time=2023-12-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193141, encodeId=ac452193141fb, content=审稿速度:1.0 偏重的研究方向：综述 经验分享：有人知道Under Review之后的Pending Recommendation是什么意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b48657909, createdName=ms2000001264592817, createdTime=Thu Mar 14 12:04:29 CST 2024, time=2024-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172808, encodeId=92fa21e2808ca, content=偏重的研究方向：临床医学 经验分享：投了四个半月还没有消息，这个期刊审稿真的好慢啊，国内好多单位都不认可ESCI的文章，这个还值得等吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vNZqQTZRAia4sz17MJeeXej9b0wqlA3jB6Acygq3dDKMnrkfLkfWibEKTPDtP1BmicPE93J1B6Z7iam0nDL5wialt9g/132, createdBy=6bee2434254, createdName=琳琳LL, createdTime=Mon Dec 04 10:34:00 CST 2023, time=2023-12-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2185051, encodeId=edca2185051ae, content=请问大家Under Review是外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Wed Jan 31 16:07:51 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183392, encodeId=d2db2183392ce, content=急急急！！！各位大佬，有人知道medcomm期刊查重用的是什么软件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adaa8754937, createdName=ms9000001623527020, createdTime=Tue Jan 23 10:44:47 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166798, encodeId=80212166e98b4, content=有人知道这个期刊什么时候能进SCIE么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sun Nov 05 13:50:31 CST 2023, time=2023-11-05, status=1, ipAttribution=江苏省)]

2024-03-14 ms2000001264592817

审稿速度:1.0
偏重的研究方向：综述
经验分享：有人知道Under Review之后的Pending Recommendation是什么意思吗

20 0

[GetPortalCommentsPageByObjectIdResponse(id=2200373, encodeId=79e422003e3dd, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：遗传学 经验分享：期刊目前还属于ESCI，非SCI。审稿速度慢，审稿人和编辑都很负责任。文章接受后等online花了将近3个月时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6495142178, createdName=smmm, createdTime=Thu Apr 25 16:52:34 CST 2024, time=2024-04-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2195131, encodeId=be792195131fe, content=审稿速度:12.0 经验分享：看了评论好像都要接受三轮修稿啊，是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fd835167, createdName=liuzhengtao, createdTime=Mon Mar 25 01:48:53 CST 2024, time=2024-03-25, status=1, ipAttribution=明尼苏达), GetPortalCommentsPageByObjectIdResponse(id=2192508, encodeId=f4ed219250817, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审4个月左右，大修，2个月后返稿继续under review中。 听说SCI目录每个月都会更新，什么时候才能进入SCIE的库呢？目前中科院分区是3区是吗？有没有知情人士说下，毕竟现在大部分院校都不承认ESCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db684799778, createdName=362595009, createdTime=Mon Mar 11 12:10:27 CST 2024, time=2024-03-11, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2189981, encodeId=96e221899819a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤药理 经验分享：23年6月2投，今天2024年2月28接收，来来回回三轮revise，只能说对文章的要求真的高，23年IF肯定＞10了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Wed Feb 28 22:00:43 CST 2024, time=2024-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2175362, encodeId=981121e536202, content=修回之后under review之后变成pending recommendation，但是后来又under review了。这是有审稿人不满意吗，还是审稿人不够啊…而且也太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epxYEMeM41N9n76P8Xn6Fy2L47YtWpP4fVuUZMZSAYnf6zW01CJWE2u7iaMTUicChIOKdsvNibjS3q7w/0, createdBy=f1fd2219511, createdName=ms5078924656919134, createdTime=Sun Dec 17 03:09:26 CST 2023, time=2023-12-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193141, encodeId=ac452193141fb, content=审稿速度:1.0 偏重的研究方向：综述 经验分享：有人知道Under Review之后的Pending Recommendation是什么意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b48657909, createdName=ms2000001264592817, createdTime=Thu Mar 14 12:04:29 CST 2024, time=2024-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172808, encodeId=92fa21e2808ca, content=偏重的研究方向：临床医学 经验分享：投了四个半月还没有消息，这个期刊审稿真的好慢啊，国内好多单位都不认可ESCI的文章，这个还值得等吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vNZqQTZRAia4sz17MJeeXej9b0wqlA3jB6Acygq3dDKMnrkfLkfWibEKTPDtP1BmicPE93J1B6Z7iam0nDL5wialt9g/132, createdBy=6bee2434254, createdName=琳琳LL, createdTime=Mon Dec 04 10:34:00 CST 2023, time=2023-12-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2185051, encodeId=edca2185051ae, content=请问大家Under Review是外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Wed Jan 31 16:07:51 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183392, encodeId=d2db2183392ce, content=急急急！！！各位大佬，有人知道medcomm期刊查重用的是什么软件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adaa8754937, createdName=ms9000001623527020, createdTime=Tue Jan 23 10:44:47 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166798, encodeId=80212166e98b4, content=有人知道这个期刊什么时候能进SCIE么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sun Nov 05 13:50:31 CST 2023, time=2023-11-05, status=1, ipAttribution=江苏省)]

2023-12-04 琳琳LL 来自广东省

偏重的研究方向：临床医学
经验分享：投了四个半月还没有消息，这个期刊审稿真的好慢啊，国内好多单位都不认可ESCI的文章，这个还值得等吗？

38 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200373, encodeId=79e422003e3dd, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：遗传学 经验分享：期刊目前还属于ESCI，非SCI。审稿速度慢，审稿人和编辑都很负责任。文章接受后等online花了将近3个月时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6495142178, createdName=smmm, createdTime=Thu Apr 25 16:52:34 CST 2024, time=2024-04-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2195131, encodeId=be792195131fe, content=审稿速度:12.0 经验分享：看了评论好像都要接受三轮修稿啊，是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fd835167, createdName=liuzhengtao, createdTime=Mon Mar 25 01:48:53 CST 2024, time=2024-03-25, status=1, ipAttribution=明尼苏达), GetPortalCommentsPageByObjectIdResponse(id=2192508, encodeId=f4ed219250817, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审4个月左右，大修，2个月后返稿继续under review中。 听说SCI目录每个月都会更新，什么时候才能进入SCIE的库呢？目前中科院分区是3区是吗？有没有知情人士说下，毕竟现在大部分院校都不承认ESCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db684799778, createdName=362595009, createdTime=Mon Mar 11 12:10:27 CST 2024, time=2024-03-11, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2189981, encodeId=96e221899819a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤药理 经验分享：23年6月2投，今天2024年2月28接收，来来回回三轮revise，只能说对文章的要求真的高，23年IF肯定＞10了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Wed Feb 28 22:00:43 CST 2024, time=2024-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2175362, encodeId=981121e536202, content=修回之后under review之后变成pending recommendation，但是后来又under review了。这是有审稿人不满意吗，还是审稿人不够啊…而且也太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epxYEMeM41N9n76P8Xn6Fy2L47YtWpP4fVuUZMZSAYnf6zW01CJWE2u7iaMTUicChIOKdsvNibjS3q7w/0, createdBy=f1fd2219511, createdName=ms5078924656919134, createdTime=Sun Dec 17 03:09:26 CST 2023, time=2023-12-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193141, encodeId=ac452193141fb, content=审稿速度:1.0 偏重的研究方向：综述 经验分享：有人知道Under Review之后的Pending Recommendation是什么意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b48657909, createdName=ms2000001264592817, createdTime=Thu Mar 14 12:04:29 CST 2024, time=2024-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172808, encodeId=92fa21e2808ca, content=偏重的研究方向：临床医学 经验分享：投了四个半月还没有消息，这个期刊审稿真的好慢啊，国内好多单位都不认可ESCI的文章，这个还值得等吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vNZqQTZRAia4sz17MJeeXej9b0wqlA3jB6Acygq3dDKMnrkfLkfWibEKTPDtP1BmicPE93J1B6Z7iam0nDL5wialt9g/132, createdBy=6bee2434254, createdName=琳琳LL, createdTime=Mon Dec 04 10:34:00 CST 2023, time=2023-12-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2185051, encodeId=edca2185051ae, content=请问大家Under Review是外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Wed Jan 31 16:07:51 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183392, encodeId=d2db2183392ce, content=急急急！！！各位大佬，有人知道medcomm期刊查重用的是什么软件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adaa8754937, createdName=ms9000001623527020, createdTime=Tue Jan 23 10:44:47 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166798, encodeId=80212166e98b4, content=有人知道这个期刊什么时候能进SCIE么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sun Nov 05 13:50:31 CST 2023, time=2023-11-05, status=1, ipAttribution=江苏省)]

2024-01-31 ms3000001872426513 来自北京

请问大家Under Review是外审吗？

33 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200373, encodeId=79e422003e3dd, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：遗传学 经验分享：期刊目前还属于ESCI，非SCI。审稿速度慢，审稿人和编辑都很负责任。文章接受后等online花了将近3个月时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6495142178, createdName=smmm, createdTime=Thu Apr 25 16:52:34 CST 2024, time=2024-04-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2195131, encodeId=be792195131fe, content=审稿速度:12.0 经验分享：看了评论好像都要接受三轮修稿啊，是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fd835167, createdName=liuzhengtao, createdTime=Mon Mar 25 01:48:53 CST 2024, time=2024-03-25, status=1, ipAttribution=明尼苏达), GetPortalCommentsPageByObjectIdResponse(id=2192508, encodeId=f4ed219250817, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审4个月左右，大修，2个月后返稿继续under review中。 听说SCI目录每个月都会更新，什么时候才能进入SCIE的库呢？目前中科院分区是3区是吗？有没有知情人士说下，毕竟现在大部分院校都不承认ESCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db684799778, createdName=362595009, createdTime=Mon Mar 11 12:10:27 CST 2024, time=2024-03-11, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2189981, encodeId=96e221899819a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤药理 经验分享：23年6月2投，今天2024年2月28接收，来来回回三轮revise，只能说对文章的要求真的高，23年IF肯定＞10了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Wed Feb 28 22:00:43 CST 2024, time=2024-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2175362, encodeId=981121e536202, content=修回之后under review之后变成pending recommendation，但是后来又under review了。这是有审稿人不满意吗，还是审稿人不够啊…而且也太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epxYEMeM41N9n76P8Xn6Fy2L47YtWpP4fVuUZMZSAYnf6zW01CJWE2u7iaMTUicChIOKdsvNibjS3q7w/0, createdBy=f1fd2219511, createdName=ms5078924656919134, createdTime=Sun Dec 17 03:09:26 CST 2023, time=2023-12-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193141, encodeId=ac452193141fb, content=审稿速度:1.0 偏重的研究方向：综述 经验分享：有人知道Under Review之后的Pending Recommendation是什么意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b48657909, createdName=ms2000001264592817, createdTime=Thu Mar 14 12:04:29 CST 2024, time=2024-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172808, encodeId=92fa21e2808ca, content=偏重的研究方向：临床医学 经验分享：投了四个半月还没有消息，这个期刊审稿真的好慢啊，国内好多单位都不认可ESCI的文章，这个还值得等吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vNZqQTZRAia4sz17MJeeXej9b0wqlA3jB6Acygq3dDKMnrkfLkfWibEKTPDtP1BmicPE93J1B6Z7iam0nDL5wialt9g/132, createdBy=6bee2434254, createdName=琳琳LL, createdTime=Mon Dec 04 10:34:00 CST 2023, time=2023-12-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2185051, encodeId=edca2185051ae, content=请问大家Under Review是外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Wed Jan 31 16:07:51 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183392, encodeId=d2db2183392ce, content=急急急！！！各位大佬，有人知道medcomm期刊查重用的是什么软件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adaa8754937, createdName=ms9000001623527020, createdTime=Tue Jan 23 10:44:47 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166798, encodeId=80212166e98b4, content=有人知道这个期刊什么时候能进SCIE么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sun Nov 05 13:50:31 CST 2023, time=2023-11-05, status=1, ipAttribution=江苏省)]

2024-01-23 ms9000001623527020 来自北京

急急急！！！各位大佬，有人知道medcomm期刊查重用的是什么软件吗？

24 0

[GetPortalCommentsPageByObjectIdResponse(id=2200373, encodeId=79e422003e3dd, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：遗传学 经验分享：期刊目前还属于ESCI，非SCI。审稿速度慢，审稿人和编辑都很负责任。文章接受后等online花了将近3个月时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6495142178, createdName=smmm, createdTime=Thu Apr 25 16:52:34 CST 2024, time=2024-04-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2195131, encodeId=be792195131fe, content=审稿速度:12.0 经验分享：看了评论好像都要接受三轮修稿啊，是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fd835167, createdName=liuzhengtao, createdTime=Mon Mar 25 01:48:53 CST 2024, time=2024-03-25, status=1, ipAttribution=明尼苏达), GetPortalCommentsPageByObjectIdResponse(id=2192508, encodeId=f4ed219250817, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审4个月左右，大修，2个月后返稿继续under review中。 听说SCI目录每个月都会更新，什么时候才能进入SCIE的库呢？目前中科院分区是3区是吗？有没有知情人士说下，毕竟现在大部分院校都不承认ESCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db684799778, createdName=362595009, createdTime=Mon Mar 11 12:10:27 CST 2024, time=2024-03-11, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2189981, encodeId=96e221899819a, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤药理 经验分享：23年6月2投，今天2024年2月28接收，来来回回三轮revise，只能说对文章的要求真的高，23年IF肯定＞10了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Wed Feb 28 22:00:43 CST 2024, time=2024-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2175362, encodeId=981121e536202, content=修回之后under review之后变成pending recommendation，但是后来又under review了。这是有审稿人不满意吗，还是审稿人不够啊…而且也太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epxYEMeM41N9n76P8Xn6Fy2L47YtWpP4fVuUZMZSAYnf6zW01CJWE2u7iaMTUicChIOKdsvNibjS3q7w/0, createdBy=f1fd2219511, createdName=ms5078924656919134, createdTime=Sun Dec 17 03:09:26 CST 2023, time=2023-12-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193141, encodeId=ac452193141fb, content=审稿速度:1.0 偏重的研究方向：综述 经验分享：有人知道Under Review之后的Pending Recommendation是什么意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b48657909, createdName=ms2000001264592817, createdTime=Thu Mar 14 12:04:29 CST 2024, time=2024-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172808, encodeId=92fa21e2808ca, content=偏重的研究方向：临床医学 经验分享：投了四个半月还没有消息，这个期刊审稿真的好慢啊，国内好多单位都不认可ESCI的文章，这个还值得等吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vNZqQTZRAia4sz17MJeeXej9b0wqlA3jB6Acygq3dDKMnrkfLkfWibEKTPDtP1BmicPE93J1B6Z7iam0nDL5wialt9g/132, createdBy=6bee2434254, createdName=琳琳LL, createdTime=Mon Dec 04 10:34:00 CST 2023, time=2023-12-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2185051, encodeId=edca2185051ae, content=请问大家Under Review是外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Wed Jan 31 16:07:51 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183392, encodeId=d2db2183392ce, content=急急急！！！各位大佬，有人知道medcomm期刊查重用的是什么软件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adaa8754937, createdName=ms9000001623527020, createdTime=Tue Jan 23 10:44:47 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166798, encodeId=80212166e98b4, content=有人知道这个期刊什么时候能进SCIE么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sun Nov 05 13:50:31 CST 2023, time=2023-11-05, status=1, ipAttribution=江苏省)]

2023-11-05 ms7000001623486299 来自江苏省

有人知道这个期刊什么时候能进SCIE么

36 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务